177 related articles for article (PubMed ID: 2423484)
1. A new supertypic HLA class II determinant (PL2) differentially expressed with DR7, DRw11(5), DRw13(w6), DRw14(w6), DR3, and DR2 and biochemically localized to DR7 molecules.
Horibe K; Knowles RW; Dupont B
Hum Immunol; 1986 May; 16(1):14-23. PubMed ID: 2423484
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and functional evidence that an MT3 supertypic determinant defined by a monoclonal antibody is carried on the DR molecule on HLA-DR7 cell lines.
Horibe K; Flomenberg N; Pollack MS; Adams TE; Dupont B; Knowles RW
J Immunol; 1984 Dec; 133(6):3195-202. PubMed ID: 6208273
[TBL] [Abstract][Full Text] [Related]
3. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
[TBL] [Abstract][Full Text] [Related]
4. Biochemical dissection of DRw6 related epitopes using monoclonal antibodies.
Johnson JP; Wank R
Hum Immunol; 1986 May; 16(1):69-80. PubMed ID: 2423487
[TBL] [Abstract][Full Text] [Related]
5. Assignment of determinants recognized by human alloantisera to HLA-D-subregion molecules by a lysostrip technique.
Nuñez G; Stastny P
Tissue Antigens; 1986 Apr; 27(4):185-95. PubMed ID: 2425451
[TBL] [Abstract][Full Text] [Related]
6. A supertypic HLA class II determinant shared by DR1 and DRw9, and crossreactive with DR2, defined by human monoclonal antibody.
Kosinski S; Yang SY; Pistillo MP; Hämmerling U
Hum Immunol; 1988 Mar; 21(3):221-31. PubMed ID: 2453492
[TBL] [Abstract][Full Text] [Related]
7. Divergent and invariant HLA class II beta chain isoelectric points.
Bontrop R; van Miltenburg R; Koning F; Gerrets R; Hyland C; Giphart M
Hum Immunol; 1986 May; 16(1):38-51. PubMed ID: 2423486
[TBL] [Abstract][Full Text] [Related]
8. HLA-DS molecules and their relation to supertypic specificities.
Goyert SM; Moriuchi J; Winchester R; Silver J
Hum Immunol; 1983 Sep; 8(1):53-63. PubMed ID: 6195135
[TBL] [Abstract][Full Text] [Related]
9. An influenza A virus-specific and HLA-DRw8-restricted T cell clone cross-reacting with a transcomplementation product of the HLA-DR2 and DR4 haplotypes.
Gomard E; Hénin Y; Sterkers G; Masset M; Fauchet R; Lévy JP
J Immunol; 1986 Jun; 136(11):3961-7. PubMed ID: 2422266
[TBL] [Abstract][Full Text] [Related]
10. Production of an HLA-DRw13 antibody in a DRw14 positive multiparous woman.
Darke C; Street J
Tissue Antigens; 1987 Jul; 30(1):42-7. PubMed ID: 3672492
[TBL] [Abstract][Full Text] [Related]
11. Molecular identifications of HLA-DR4, MT3, and TB21 antigens on HLA-DR4 homozygous B cell lines.
Maeda H; Hirata R
J Immunol; 1984 Feb; 132(2):574-7. PubMed ID: 6418807
[TBL] [Abstract][Full Text] [Related]
12. Separation of four class II molecules from DR2 and DRw6 homozygous B lymphoid cell lines.
Maeda H; Hirata R
Immunogenetics; 1984; 20(6):639-47. PubMed ID: 6392082
[TBL] [Abstract][Full Text] [Related]
13. A monoclonal antibody detecting an HLA-DQwl-related determinant.
Koning F; Raghoebar J; Schreuder GM; Schuurman R; Bruning H
Tissue Antigens; 1985 Aug; 26(2):100-9. PubMed ID: 2414859
[TBL] [Abstract][Full Text] [Related]
14. Identification of cross-reactive T cell restriction epitopes located on the DR7 beta 1 and DR beta 4 molecules.
Bismuth G; Gouy H; Karr RW; Debré P
Hum Immunol; 1990 Jul; 28(3):271-83. PubMed ID: 1695622
[TBL] [Abstract][Full Text] [Related]
15. Molecular, serologic, and functional evidence for an apparent HLA-DR triplet.
Bontrop RE; Schreuder GM; Elferink DG; Mikulski MM; Geerse R; Giphart MJ
J Immunol; 1986 Jul; 137(1):211-6. PubMed ID: 3486913
[TBL] [Abstract][Full Text] [Related]
16. Quantitative expression of epitopes defined by murine monoclonal antibodies on DR molecules from different HLA haplotypes.
Letarte M; Addis J; Iturbe S; Petsche D
Biosci Rep; 1985; 5(10-11):923-31. PubMed ID: 2420387
[TBL] [Abstract][Full Text] [Related]
17. Identification of HLA-DRw52 associated antigens using HLA class II allogenotyping.
Savage DA; Bidwell JL; Cullen C; Bidwell EA; Middleton D
Tissue Antigens; 1988 Nov; 32(5):278-85. PubMed ID: 2464859
[TBL] [Abstract][Full Text] [Related]
18. Identification of the MT3 molecule from HLA-DR4, 7, and w9 homozygous cell lines.
Mukai R; Suzuki M; Yabe T; Hamaguchi H; Maeda H
J Immunol; 1984 Dec; 133(6):3211-9. PubMed ID: 6436378
[TBL] [Abstract][Full Text] [Related]
19. Inherited susceptibility to insulin-dependent diabetes is associated with HLA-DR1, while DR5 is protective.
Maclaren N; Riley W; Skordis N; Atkinson M; Spillar R; Silverstein J; Klein R; Vadheim C; Rotter J
Autoimmunity; 1988; 1(3):197-205. PubMed ID: 2979618
[TBL] [Abstract][Full Text] [Related]
20. The monoclonal antibody AC1.59 defines a new polymorphic determinant on HLA-DR molecules.
Crepaldi T; Richiardi P; Malavasi F; Carbonara AO; Igarashi M; Ferrone S
Tissue Antigens; 1985 Jul; 26(1):25-34. PubMed ID: 2412306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
